Transcranial magnetic stimulation (TMS) is an FDA approved, safe treatment for adults with medication-resistant depression. TMS involves the use of a very short pulsed magnetic field to stimulate nerve cells in a part of the brain that regulates mood. This area has been found to be underactive in individuals suffering from depression, who may benefit from TMS as an alternative treatment option for those who have not found success with prior antidepressant medications.
• Non-invasive, outpatient procedure
• Patients are awake and alert during treatment
• Uses precisely targeted magnetic pulses
• Stimulates key areas of the brain that are underactive in patients with depression
• Free from side effects often associated with antidepressant medication
Neurotransmitters are chemicals in the brain that communicate information throughout our brain and body. For those living with depression, this essential communication has decreased or been disrupted. TMS Therapy works by using electromagnetic pulses to stimulate neurons, and cause the release of more neurotransmitters. Local stimulation depolarizes neurons, which can have an effect on deeper brain regions involved in mood.
• A typical course of treatment occurs 5 days a week for 4-6 weeks
• A physician is present to customize treatment dose and placement for each patient
• Daily treatment consists of 4 seconds of rapid magnetic pulses, followed by a 26 minute pause for a total of 37 minutes each day
• Magnetic pulses are described as feeling like an small, electronic woodpecker tapping on the scalp
TMS Therapy provides relief for patients who do not adequately respond to medication, or who find the adverse effects of antidepressant medication intolerable. While antidepressant medications are often accompanied by symptoms such as insomnia, weight gain, nausea, fatigue and sexual dysfunction, the most common side effect associated with TMS Therapy is temporary slight pain or discomfort at or near the treatment site during treatment. These events are transient and usually subside after the first week of treatment.
TMS Therapy has no adverse effect on cognition, memory, or daily functioning. Once a patient has completed their treatment for the day, they are able to drive, go to work, and carry out their normal daily routine.
Individuals may not be eligable for TMS Therapy if they have any non-removeable metallic objects in or near their head or neck or implanted devices controlled by physiological signals, such as a pacemaker, cardiovascular defibrillator (ICD) or vagus nerve stimulator (VNS). This does not include dental work (e.g., fillings and implants). Those who have a history of seizure may also be disqualified from treatment on a case-by-case basic.
• Over 30,000 patients treated
• 7 major studies including 800 patients, resulting in 18 publications
• Learn more about proven short- and long-term efficacy of NeuroStar TMS Therapy at www.neurostar.com
In a study of 307 patients undergoing an initial ("acute") course of TMS Therapy where the majority of patients were considered severely depressed, clinicians found that approximately 58% were assessed as 'mildly ill or better' by the end of treatment.
Patients may see an improvement in their depressive symptoms at any time over the course of treatment. While some patients may see an improvement after the first week, it is just as common for patients to notice an improvement within their last couple weeks of treatment.
The use of TMS Therapy as a therapeutic tool in the mental-health industry is ever-expanding. While TMS Therapy has only gained FDA-approval for the treatment of Major Depressive Disorder, numerous studies have found TMS to produce significant clinical effects for various other neurological and psychiatric conditions. Additional applications of TMS Therapy include, but are not limited to:
• Anxiety - Obsessive Compulsive Disorder (OCD)
• Auditory Hallucinations
• Neuropathic Pain
If you are suffering from one of these conditions, call (425) 412-8133 or contact us at firstname.lastname@example.org to learn more about how TMS Therapy may provide long-awaited relief for you.
What is TMS Therapy?
What happens during TMS Therapy? What is the Mechanism of Action?
How long does a patient undergo TMS therapy?
What is a daily treatment session like?
What are the benefits of TMS?
How long does the antidepressant effect last? Do patients need to go back for another session?
Is TMS therapy a good alternative for patients who are fearful of the side effects associated with antidepressant medications?
What does TMS feel like during treatment?
What are the long-term consequences of TMS treatment?
What are the risks of TMS therapy?
How effective is TMS therapy compared with drugs?
Is TMS therapy intended to replace antidepressant medications?
What is the history of TMS therapy?
Will treatment be covered by insurance and/or Medicare?
Is TMS therapy like ECT (electro-convulsive therapy or “shock treatment”)?
TMS Therapy is a non-systemic (does not circulate in the bloodstream throughout the body) and non-invasive (does not involve surgery) form of neuromodulation, which stimulates nerve cells in specific areas of the brain that are linked to various neuropsychiatric conditions, by delivering highly focused MRI- strength magnetic pulses directly through the scalp. Patients being treated by TMS Therapy do not require anesthesia or sedation and remain awake and alert during the treatment session. For depression, it is a 45-minute outpatient procedure that is prescribed by a psychiatrist and performed in a psychiatrist’s office. The treatment is typically administered daily for 4-6 weeks for Depression. Treatment protocols for other psychiatric or neurologic conditions vary in session length and number of sessions needed.Done
During TMS Therapy for depression, pulsed magnetic fields are repetitively transmitted into the left prefrontal cortex, the part of the brain that is thought to regulate mood, in order to stimulate the firing of neurons (nerve cells). This is believed to trigger a cascade of neurochemical events, including the release of neurotransmitters (such as serotonin, norepinephrine, and dopamine) and to help normalize neurotransmitter function.Done
In clinical trials for depression, patients received TMS Therapy 5 times per week for approximately 37 minutes during each session for 4-6 weeks. Patients with depression should be treated for a minimum of four weeks with additional treatments based on clinical judgment. This standard does not apply for those seeking treatment for other neuropsychiatric disorders, such as auditory hallucinations or tinnitus, which often require much shorter treatment protocols.Done
At the start of treatment, patients are seated in a comfortable chair in a slightly reclined position. The clinician will speak with the patient about any updates, medication changes, concerns or questions the patient may have each day. During treatment, the patient may listen to music, watch a show (device not provided), read a book, practice breathing or mindfulness techniques, or sit silently with earplugs in. The patient must stay awake during treatment.Done
1. TMS Therapy is a non-systemic and non-invasive depression treatment that is cleared by the FDA for depression
2. It is indicated for adult patients who did not achieve satisfactory improvement from prior antidepressant medication
3. In clinical trials, approximately 60% of patients showed a significant improvement in symptoms after 4-6 weeks of treatment
4. Since it’s non-systemic, it doesn't have side effects such as weight gain, sexual dysfunction, nausea, sedation, dry mouth, etc.
In a long-term durability study of 257 patients with Major Depressive Disorder by Dunner et al., (2014), approximately 62% of patients continued to meet response criteria a year later. However, 32% of patients experienced symptom worsening a month after completing treatment, and had to go back for additional treatment sessions. Of the patients who responded to the initial course of treatment and then experienced symptom worsening, all of those patients responded equally as well to reintroduction TMS treatment the second time around.
It is important to note that these statistics vary by clinic and the neuropsychiatric condition for which you are seeking treatment. Since TMS Therapy has only been FDA approved for depression since 2008, there is no standard for how long TMS is “supposed” to last, and its effects have been found to vary from months to years depending on the individual.
TMS Therapy has been cleared by the U.S. FDA for the treatment of patients with depression who have failed to achieve satisfactory improvement from prior antidepressant treatment.
TMS Therapy is non-systemic, so it doesn’t have side effects such as weight gain, sexual dysfunction, nausea, dry mouth, sedation, etc.
Like any treatment option, patients and clinicians should work together to find the most appropriate treatment option for each patient.
TMS Therapy has been described as sounding and feeling like an electronic woodpecker tapping on the scalp. The most common adverse event related to treatment was scalp pain or discomfort at the treatment area during active treatments, which was transient and mild to moderate in severity. The incidence of this side effect declined markedly after the first week of treatment.Done
TMS is an acute (active, but short-term) therapy. With regard to long-term safety, TMS uses the same type and strength of magnetic fields as MRIs, which have been used in tens of millions of patients around the world and have not been shown to cause long-term consequences.
The amount of magnetic field exposure for a full course of TMS Therapy is only a small fraction of one brain scan with an MRI. If a patient had multiple courses of acute TMS, the magnetic field exposure would be less than exposure from a few MRI sessions.
TMS Therapy is contraindicated (should not be used) in patients with implanted metallic devices or non-removable metallic objects in or around the head. This does not apply to dental work. It also should not be used in patients with implanted devices that are controlled by physiological signals such as pacemakers. Patients with a seizure disorder or a history of seizure should consult their physician about whether TMS is an appropriate treatment option.
Some people experience slight discomfort at the treatment site or headache during the first few treatment sessions. These usually resolve by the second week of therapy.
The risk of seizures is extremely low and is estimated to be less than 1 in 1000.
TMS Therapy is meant for patients who have already tried multiple antidepressant medications and discontinued them due to a lack of response or intolerable side effects. Due to the nature of these qualifications, TMS Therapy has been found to be a much more successful therapeutic tool compared to patients trying a third or fourth medication trial that are often accompanied by potentially severe side effects.Done
No, there is a significant unmet need in the treatment of depression. Currently there are few options for patients who have had an inadequate response to previous antidepressant treatments. They are often faced with choosing between a complex regimen of multiple drugs or, for more severe cases, more invasive procedures. Based on its excellent safety profile, TMS Therapy may be used earlier in the treatment algorithm than antidepressant drug classes that carry a significant safety/tolerability burden.Done
First used in 1985, TMS has been used by researchers around the world to help understand the function of different parts of the brain. Several hundred manuscripts have been published regarding its use in stimulating select regions of the brain. Since the mid 1990s, TMS has been studied as an antidepressant therapy. In 2006, Neuronetics completed the largest randomized, controlled study ever conducted with TMS Therapy. In 2008, TMS therapy was cleared by the U.S. Food and Drug Administration for the treatment of adult patients with major depressive disorder who have failed to receive satisfactory improvement from prior medication antidepressant treatment. Many clinical studies are still underway to determine the effectiveness of TMS therapy as an optimal treatment method for various other neurological and psychiatric conditions.Done
While Spero Consulting PLLC is “out of network” for general psychiatry services, we do offer to conduct a free benefits investigation for those interested in TMS Therapy to see if TMS is covered under their specific insurance plan. For those who meet the criteria for major depressive disorder, we can file a single-case agreement with insurance companies on a case-by-case basis to provide you “in-network” coverage for TMS. Unfortunately, we will not be accepting Medicare insurance as we have opted-out of Medicare. TMS Therapy for conditions other than Major Depressive Disorder are also cash-pay only, as they have not been approved for coverage by any insurance company at this time.Done
No, TMS Therapy is a completely different procedure than ECT. While they are both considered to be secondary treatment options to medication and psychotherapy, they do not treat depression in the same manner. ECT is a procedure that requires general anesthesia and purposefully triggers a brief seizure by passing electric currents through the brain. TMS, on the other hand, allows for the patient to be fully awake and alert during treatment and uses non-invasive magnetic fields to directly stimulate nerve cells in a specific area of the brain. Furthermore, TMS does not produce any of the unwanted side effects that are often associated with ECT, such as confusion, memory loss, physical side effects, and medical complications. TMS Therapy does not result in adverse effects on memory, concentration, or daily functioning.Done